Pacira BioSciences, Inc. — Director's Dealing 2017

Jun 8, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2017-06-05

Reporting Person: Jones James B (SVP & Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-05	Common Stock	S	767	$43.321	Disposed	9813	Direct

Footnotes

F1: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2: Includes 330 shares of common stock acquired under the issuer's employee stock purchase plan in June 2016.